AVOQ, LLC

Lobbying for OMEROS CORPORATION · Commercial-stage biopharmaceutical company

Filing 2nd Quarter - Termination

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jun 11, 2025

Income

$20,000.00

What the client paid this registrant for the period.

Client based in

Washington

Representation ended

Jun 11, 2025

The registrant reported terminating its work for this client.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Health Issues

General monitoring of health care issues

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.